A nurse is caring for a patient who received an allogeneic hematopoietic stem cell transplant 21 days ago. Which assessment finding would be the highest priority concern requiring immediate intervention?

New rash with diarrhea and elevated liver enzymes indicates acute GVHD, a life-threatening complication requiring immediate immunosuppressive therapy. Other findings are less urgent.

Core Nursing Explanation Key Concept Analysis: This question assesses the nurse's ability to recognize and prioritize life-threatening complications in a post-hematopoietic stem cell transplant (HSCT) patient. The critical time frame is "21 days post-transplant," which falls within the period when acute Graft-versus-Host Disease (GVHD) typically manifests. GVHD occurs when the donor's immune cells (the graft) attack the recipient's (host's) tissues. The classic triad for acute GVHD involves the Key Point! skin, gastrointestinal (GI) tract, and liver. The presentation in option ③—rash, diarrhea, and elevated liver enzymes—is a hallmark of this systemic, potentially fatal complication that requires urgent immunosuppressive intervention to prevent organ damage and death.

Answer Rationale: Option ③ is correct because it describes a classic presentation of acute GVHD. The new rash indicates skin involvement, diarrhea points to GI tract attack, and elevated liver enzymes (like ALT, AST) signal liver involvement. This combination represents a Key Point! systemic inflammatory response that can rapidly progress, leading to severe organ dysfunction, fluid and electrolyte imbalances from diarrhea, and increased mortality if not treated immediately with medications like corticosteroids, tacrolimus, or cyclosporine.

Distractor Analysis:
Watch out for confusion! Option ①: A low-grade fever (100.2°F/37.9°C) with fatigue is common post-transplant and could indicate a minor infection or simply the recovery process. While infection is always a concern in immunocompromised patients, this finding alone is not as immediately life-threatening as systemic GVHD.
Watch out for confusion! Option ②: Thrombocytopenia (platelet count 25,000/μL) with petechiae indicates a risk for bleeding. This requires monitoring and may necessitate platelet transfusions, but it is an expected complication during the engraftment period and does not represent the same acute, systemic inflammatory crisis as GVHD.
Watch out for confusion! Option ④: Leukopenia (WBC 1,200/μL) with neutropenia is also an expected finding after transplant before full engraftment. It signifies a high risk for infection, which is a major concern. However, the question asks for the highest priority concern requiring immediate intervention. While neutropenia requires protective isolation and vigilant monitoring, the active, multi-organ inflammatory process of acute GVHD presents a more direct and immediate threat to organ function and survival.

Related Concepts: The nursing priority follows the ABCs (Airway, Breathing, Circulation) and threat-to-life principles. GVHD threatens circulation (through fluid loss from diarrhea leading to hypovolemia) and organ function. Understanding the timeline of HSCT complications is crucial: early phase (engraftment, infection, bleeding), mid-phase (acute GVHD, days 21-100), and late phase (chronic GVHD).

Nursing Clinical Practice Guide Clinical Scenario: You are the nurse on an oncology/BMT (Bone Marrow Transplant) unit. Your patient, Mr. Johnson, is day 21 post-allogeneic stem cell transplant for acute myeloid leukemia (AML). During your morning assessment, he mentions new itching and you observe a faint, red, maculopapular rash on his palms, soles, and trunk. He also reports having 4 loose, watery stools since midnight, and his morning lab results show ALT of 150 U/L (normal ~40 U/L).

Nursing Intervention Strategy: 1. Immediate Assessment & Notification: Perform a focused assessment of all three target organs. Grade the rash (mild, moderate, severe), quantify and characterize diarrhea (volume, consistency, presence of blood), and review all liver function tests. Immediately notify the transplant physician and BMT coordinator. This is not a "wait and see" situation. 2. Supportive Care: Initiate contact and standard precautions if neutropenic. Provide meticulous skin care with gentle, fragrance-free lotions and avoid harsh soaps. For diarrhea, implement strict intake and output (I&O) monitoring, administer antidiarrheals as ordered (e.g., loperamide), and provide a low-residue, bland diet. Monitor for signs of dehydration and electrolyte imbalances. 3. Medication Administration: Be prepared to administer high-dose intravenous (IV) corticosteroids (e.g., methylprednisolone) as first-line therapy for acute GVHD. Administer other immunosuppressants (tacrolimus, cyclosporine) exactly on schedule, monitoring therapeutic drug levels and side effects (nephrotoxicity, neurotoxicity, hypertension). 4. Patient & Family Education: Explain GVHD in simple terms: "The new immune system from the donor is reacting against your body." Educate on the importance of reporting any new skin changes, abdominal pain, or changes in stool immediately. Reinforce infection prevention measures, as immunosuppressive therapy increases infection risk further.

Patient Safety and Precautions: Key Point! Never administer live vaccines to a patient on immunosuppressive therapy for GVHD. Be vigilant for signs of superimposed infection (e.g., fever, cough), as the patient is "doubly immunocompromised" from both the transplant and the GVHD treatment. Monitor for adrenal insufficiency if on long-term steroids.

Nursing Procedure & Medication Flow GVHD Assessment & Grading (Nursing Role): 1. Skin: Assess body surface area (BSA) involved. A rash on >50% BSA indicates severe (Grade III-IV) GVHD. 2. GI: Measure stool volume. >1,500 mL/day indicates severe GI GVHD. 3. Liver: Track bilirubin levels. Bilirubin >3.0 mg/dL indicates liver involvement.
Immunosuppressant Administration: - Tacrolimus/Cyclosporine: Administer IV or PO at exact times. Draw trough levels immediately before the next dose. Monitor for tremors, headache, hypertension, and renal function (BUN/Creatinine). - Corticosteroids: Administer IV methylprednisolone per protocol (e.g., 2 mg/kg/day). Taper slowly to avoid adrenal crisis. Monitor for hyperglycemia, mood changes, and increased infection risk.

A Word from Your Senior Nurse "In the world of BMT nursing, we walk a tightrope between hope (the new immune system fighting cancer) and risk (that same system attacking the patient). Day 21 is a critical juncture. Your eyes and assessment skills are the earliest warning system for GVHD. That faint rash isn't just a rash; it's the first flare of a potential firestorm. When you see the triad—skin, gut, liver—think SYSTEMIC, think URGENT. Your prompt recognition and action directly save lives and preserve the success of the transplant. On the NCLEX, they test this priority-setting constantly: not just what's abnormal, but what's the most immediate threat to life or organ function. In this case, GVHD wins that race every time."